… have a low rate of tumor recurrence. The objectives of this study were to evaluate the rate of
early tumor recurrence in patients with intermediate-risk papillary thyroid cancer who had an …

… Our results suggest that RAI is associated with improved OS in intermediate-risk patients
with papillary thyroid cancer. Our study is adequately powered to detect true differences in …

… Our results might help to identify additional significant risk factors for intermediate risk
and to stratify the risk groups to improve the prediction of posttreatment recurrence. …

… They concluded that there was no benefit of TSH suppression therapy in low-risk patients
[… in low-risk PTC patients [17]. As for intermediate- and high-risk thyroid cancer patients, two …

… to the remaining intermediate risk patients, and show that they can be classified in clinically
meaningful risk groups, characterized by established prognostic disease phenotypes. …

… We identify from our database patients with papillary thyroid cancer who underwent surgery
in our hospital and were stratified to be of intermediate risk from the GAMES stratification …

… risk stratify patients into low, intermediate, and high risk of death (Table I). In patients categorized
as low or intermediate risk, … in low- and intermediate-risk patients with PTC who had an …

… Objective: Guidelines recommend thyroid-… in papillary thyroid cancer (PTC) patients. The
aim of this study was to assess the rate of structural disease (SD) in low- and intermediate-risk …

… 1.93, 95% confidence interval 1.61 to 2.32), lymph node metastasis (1.32, 1.20 to 1.45),
extrathyroidal extension (1.71, 1.50 to 1.94), and advanced stage thyroid cancer (1.70, 1.45 to …

… decrease recurrence in intermediate-risk patients with papillary thyroid microcarcinoma [21]. …
effect of RAI therapy on disease recurrence in intermediate-risk patients. The authors found …